Pharmafile Logo
Pharmafocus logo
Advanced Search

research and development

Showing 15 posts of 209 posts found.

Edinburgh BioQuarter appoints commercialisation director

March 16, 2010
Research and Development Edinburgh BioQuarter, appointment, research and development

Dr Michael Capaldi has joined Scottish life sciences research hub Edinburgh BioQuarter as director of commercialisation. He will lead a …

Appointment
GSKstephenne

GSK promotes Jean Stephenne to chairman, biologicals

March 15, 2010
Research and Development, Sales and Marketing GlaxoSmithKline, appointment, research and development, sales and marketing

GlaxoSmithKline has appointed Jean Stephenne chairman of GSK Biologicals, the company’s global vaccines division.He is currently president and general manager of …

Appointment
Andreotti

Lamberto Andreotti new head of Bristol-Myers Squibb

March 4, 2010
Research and Development, Sales and Marketing BMS, appointment, research and development, sales and marketing

Bristol-Myers Squibb has appointed Lamberto Andreotti its new chief executive with effect from 4 May, succeeding James Cornelius who will …

Appointment

Kinex Pharmaceuticals appoints Rudolf Kwan

March 2, 2010
Research and Development Kinex Pharmaceuticals, appointment, research and development

Dr Rudolf Kwan has joined Buffalo, US-based  Kinex Pharmaceuticals as chief medical officer. He will be responsible for the design …

Appointment

Lilly UK appoints Ramona Sequeira managing director

February 23, 2010
Research and Development, Sales and Marketing appointment, lilly, research and development, sales and marketing

Lilly UK has appointed Ramona Sequeira managing director, UK and Republic of Ireland.She replaces Andrew Hotchkiss who becomes vice president …

Appointment

Clinipace appoints Bud Owen and Daryl Porter

February 19, 2010
Research and Development Clinipace, appointment, research and development

CRO and eClinical technology specialist Clinipace Worldwide has appointed Bud Owen as its chief financial officer, while Daryl Porter has …

Appointment

Dr Jay Feingold joins Daiichi Sankyo

February 19, 2010
Research and Development Daiichi Sankyo, appointment, research and development

Daiichi Sankyo’s US arm has appointed Dr Jay Feingold vice president of medical affairs. In this role his will manage …

Appointment

Wyeth’s Dr Graham Cook joins British Pharmacopoeia Commission

February 18, 2010
Research and Development, Sales and Marketing Wyeth Pharmaceuticals, appointment, research and development, sales and marketing

Dr Graham Cook, a senior director in the Global Quality and Compliance division of Wyeth Pharmaceuticals, has joined the British …

Appointment

Dr Steven Leventer to head up neuroscience research for PharmaNet

February 17, 2010
Research and Development PharmaNet, appointment, research and development

PharmaNet Development Group has named Dr Steven Leventer to the position of vice president, clinical research – neuroscience. Leventer joins …

Appointment

Amarin appoints Jan van Heek

February 15, 2010
Research and Development, Sales and Marketing Amarin, appointment, research and development, sales and marketing

Jan van Heek has joined Amarin’s board of directors of as a non-executive director and will also take on the role …

Appointment

ICON promotes Tom O’Leary

February 9, 2010
Research and Development ICON, appointment, research and development

Tom O’Leary has been appointed president of ICON Central Laboratories, succeeding Bob Scott-Edwards. Scott-Edwards had held the role since August …

Appointment
Photo_Miguel_Forte300dpi

Miguel Forte joins TxCell

February 5, 2010
Research and Development TxCell, appointment, research and development

French biotech TxCell has appointed Miguel Forte to fill its newly-created role of chief medical officer. Miguel joins the company …

Appointment

Cell Medica bolsters senior management

January 28, 2010
Research and Development Cell Medica, appointment, research and development

London-based cellular therapeutics company Cell Medica has made four key appointments. Dr Rainer Knaus joins the company as senior vice …

Appointment

BioCeramic Therapeutics appoints Ian Brown

January 27, 2010
Research and Development BioCeramic Therapeutics, appointment, research and development

BioCeramic Therapeutics has appointed Ian Brown chief executive, taking over from Daniel Green who will remain on the board as …

Appointment
Clavis Olav Hellebo

Clavis Pharma appoints Olav Hellebø

January 25, 2010
Research and Development, Sales and Marketing Clavis Pharma, appointment, research and development, sales and marketing

Norwegian cancer drug development company Clavis Pharma has appointed Olav Hellebø as its new chief executive. He joins the company …

Appointment
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026